Dr Haly
@halydoc
Hepatology Consultant at Barts Health with an interest in MASLD
ID: 1251609068264984583
18-04-2020 20:30:41
28 Tweet
46 Followers
109 Following
Pan-#PPAR agonists combine the beneficial effects of selective PPAR agonists and may counteract #inflammation and disease progression more potently in #NAFLD bit.ly/3fnFkh8 Charité - Universitätsmedizin Berlin #NASH
Please join us in the launch of NAFLD: Sounding the alarm on a global public health challenge Jeffrey V. Lazarus @HenryEMark The Economist #livertwitter economist.zoom.us/webinar/regist…
What a day for it 👌 Tune in at 16:00 BST to watch live coverage of the @Premier15s final between Saracens Women and Harlequins Women 🃏 🏆 Live on Rugby on TNT and Premier15s.com 🎬 Danielle (Nolli) Waterman 🌹
Our new review is out! - What’s new in non-alcoholic fatty liver disease? Frontline Gastro Jessica Dr Hal Brindley William Alazawi Barts Hepatology fg.bmj.com/content/early/…
Announcing the first concert of our new season The Actors’ Church Dominic Ellis-Peckham and special guests, celebrating #Schütz350 - TICKETS ON SALE NOW actorschurch.org/whatson/schutz…
Great to see our collaboration with Barts Hepatology William Alazawi presented during the metabolic poster tour by the fantastic Hal Brindley! #PRELUDE1trial. Arise 🍊$30 🍊ONLY Kush Abeysekera
📑 Health care–related transportation insecurity is associated with adverse health outcomes among adults with chronic liver disease‼️ 🚙 Transportation insecurity is associated with ⬆️ healthcare use and 💀 #LiverTwitter Nneka N. Ufere, MD MSCE Marina Serper, MD, MS journals.lww.com/hepcomm/fullte…